A. Abbas, P. Hedlund, X. Huang, T. Tran, H. Meltzer et al., Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo, Psychopharmacology, vol.16, issue.Suppl 4, pp.119-128, 2009.
DOI : 10.1007/s00213-009-1521-8

P. Arguello and J. Gogos, Modeling Madness in Mice: One Piece at a Time, Neuron, vol.52, issue.1, pp.179-196, 2006.
DOI : 10.1016/j.neuron.2006.09.023

A. Auclair, A. Cathala, F. Sarrazin, R. Depoortère, P. Piazza et al., The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity, J Neurochemistry, vol.114, issue.5, pp.1323-1332, 2010.

S. Banas, S. Doly, K. Boutourlinsky, S. Diaz, A. Belmer et al., Deconstructing Antiobesity Compound Action: Requirement of Serotonin 5-HT2B Receptors for Dexfenfluramine Anorectic Effects, Neuropsychopharmacology, vol.138, issue.2, pp.423-433, 2011.
DOI : 10.1038/npp.2010.173

URL : https://hal.archives-ouvertes.fr/hal-00583533

L. Bevilacqua, S. Doly, J. Kaprio, Q. Yuan, R. Tikkanen et al., A population-specific HTR2B stop codon predisposes to severe impulsivity, Nature, vol.43, issue.7327, pp.1061-1066, 2010.
DOI : 10.1038/nature09629

URL : https://hal.archives-ouvertes.fr/inserm-00550376

J. Blundell, C. Blaiss, M. Etherton, F. Espinosa, K. Tabuchi et al., Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior, Journal of Neuroscience, vol.30, issue.6, pp.2115-2129, 2010.
DOI : 10.1523/JNEUROSCI.4517-09.2010

B. Boutrel, B. Franc, R. Hen, M. Hamon, and A. J. , Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice, J Neurosci, vol.19, issue.8, pp.3204-3212, 1999.

W. Cai, J. Blundell, J. Han, R. Greene, and C. Powell, Postreactivation Glucocorticoids Impair Recall of Established Fear Memory, Journal of Neuroscience, vol.26, issue.37, pp.9560-9566, 2006.
DOI : 10.1523/JNEUROSCI.2397-06.2006

S. Diaz, S. Doly, N. Narboux-nême, S. Fernandez, P. Mazot et al., 5-HT2B receptors are required for serotonin-selective antidepressant actions, Molecular Psychiatry, vol.351, issue.2, pp.154-163, 2012.
DOI : 10.1038/mp.2011.159

URL : https://hal.archives-ouvertes.fr/inserm-00652573

S. Diaz and L. Maroteaux, Implication of 5-HT2B receptors in the serotonin syndrome, Neuropharmacology, vol.61, issue.3, pp.495-502, 2011.
DOI : 10.1016/j.neuropharm.2011.01.025

URL : https://hal.archives-ouvertes.fr/inserm-00561473

S. Doly, J. Bertran-gonzalez, J. Callebert, A. Bruneau, S. Banas et al., Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice, PLoS ONE, vol.4, issue.11, p.7952, 2009.
DOI : 10.1371/journal.pone.0007952.g005

URL : https://hal.archives-ouvertes.fr/inserm-00484504

S. Doly, E. Valjent, V. Setola, J. Callebert, D. Herve et al., Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro, Journal of Neuroscience, vol.28, issue.11, pp.2933-2940, 2008.
DOI : 10.1523/JNEUROSCI.5723-07.2008

URL : https://hal.archives-ouvertes.fr/inserm-00484533

K. Gleason, S. Birnbaum, A. Shukla, and S. Ghose, Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia, Translational Psychiatry, vol.191, issue.11, p.199, 2012.
DOI : 10.1093/schbul/sbq079

J. Gordon, Testing the glutamate hypothesis of schizophrenia, Nature Neuroscience, vol.63, issue.1, pp.2-4, 2010.
DOI : 10.1038/nn0110-2

H. Gunduz-bruce, The acute effects of NMDA antagonism: From the rodent to the human brain, Brain Research Reviews, vol.60, issue.2, pp.279-286, 2009.
DOI : 10.1016/j.brainresrev.2008.07.006

A. Hervas, C. Toma, P. Romaris, M. Ribases, M. Salgado et al., The involvement of serotonin polymorphisms in autistic spectrum symptomatology, Psychiatric Genetics, vol.24, issue.4, pp.158-163, 2014.
DOI : 10.1097/YPG.0000000000000034

J. Hirvonen, T. Van-erp, J. Huttunen, S. Aalto, K. Nagren et al., Increased Caudate Dopamine D2 Receptor Availability as a Genetic Marker for Schizophrenia, Archives of General Psychiatry, vol.62, issue.4, pp.371-378, 2005.
DOI : 10.1001/archpsyc.62.4.371

T. Humby and L. Wilkinson, Assaying dissociable elements of behavioural inhibition and impulsivity: translational utility of animal models, Current Opinion in Pharmacology, vol.11, issue.5, pp.534-539, 2011.
DOI : 10.1016/j.coph.2011.06.006

S. Kantor, R. Jakus, B. Balogh, A. Benko, and G. Bagdy, receptor by the subtype-selective antagonist SB-215505, British Journal of Pharmacology, vol.81, issue.8, pp.1332-1342, 2004.
DOI : 10.1038/sj.bjp.0705887

M. Keshavan, R. Tandon, N. Boutros, and H. Nasrallah, Schizophrenia, ???just the facts???: What we know in 2008Part 3: Neurobiology, Schizophrenia Research, vol.106, issue.2-3, pp.89-107, 2008.
DOI : 10.1016/j.schres.2008.07.020

. Cariprazine, a dopamine D(3) receptor-preferring) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile, J Pharmacol Exp Ther, vol.333, issue.321, pp.328-340

M. Kvajo, H. Mckellar, and J. Gogos, Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models, Neuroscience, vol.211, pp.136-164, 2012.
DOI : 10.1016/j.neuroscience.2011.07.051

J. Launay, B. Schneider, S. Loric, D. Prada, M. Kellermann et al., Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells, The FASEB Journal, vol.20, issue.11, pp.1843-1854, 2006.
DOI : 10.1096/fj.06-5724com

C. Lena, D. Popa, R. Grailhe, P. Escourrou, J. Changeux et al., ??2-Containing Nicotinic Receptors Contribute to the Organization of Sleep and Regulate Putative Micro-Arousals in Mice, Journal of Neuroscience, vol.24, issue.25, pp.5711-5718, 2004.
DOI : 10.1523/JNEUROSCI.3882-03.2004

R. Lubow and A. Moore, Latent inhibition: The effect of nonreinforced pre-exposure to the conditional stimulus., Journal of Comparative and Physiological Psychology, vol.52, issue.4, pp.415-419, 1959.
DOI : 10.1037/h0046700

L. Lyon, L. Saksida, and T. Bussey, Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models, Psychopharmacology, vol.115, issue.Suppl, pp.647-672, 2012.
DOI : 10.1007/s00213-011-2536-5

H. Meltzer, Update on Typical and Atypical Antipsychotic Drugs, Annual Review of Medicine, vol.64, issue.1, pp.393-406, 2013.
DOI : 10.1146/annurev-med-050911-161504

H. Meltzer and B. Massey, The role of serotonin receptors in the action of atypical antipsychotic drugs, Current Opinion in Pharmacology, vol.11, issue.1, pp.59-67, 2011.
DOI : 10.1016/j.coph.2011.02.007

U. Meyer, J. Feldon, M. Schedlowski, and Y. Bk, Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia, Neuroscience & Biobehavioral Reviews, vol.29, issue.6, pp.913-947, 2005.
DOI : 10.1016/j.neubiorev.2004.10.012

J. Monti and D. Monti, Sleep in schizophrenia patients and the effects of antipsychotic drugs, Sleep Medicine Reviews, vol.8, issue.2, pp.133-148, 2004.
DOI : 10.1016/S1087-0792(02)00158-2

J. Olesen, A. Gustavsson, M. Svensson, H. Wittchen, and B. Jonsson, The economic cost of brain disorders in Europe, European Journal of Neurology, vol.21, issue.Suppl. 14, pp.155-162, 2012.
DOI : 10.1111/j.1468-1331.2011.03590.x

J. Peca, C. Feliciano, J. Ting, W. Wang, M. Wells et al., Shank3 mutant mice display autistic-like behaviours and striatal dysfunction, Nature, vol.90, issue.7344, pp.437-442, 2011.
DOI : 10.1038/nature09965

P. Pitychoutis, E. Pallis, H. Mikail, and Z. Papadopoulou-daifoti, Individual differences in novelty-seeking predict differential responses to chronic antidepressant treatment through sex- and phenotype-dependent neurochemical signatures, Behavioural Brain Research, vol.223, issue.1, pp.154-168, 2011.
DOI : 10.1016/j.bbr.2011.04.036

D. Popa, C. Lena, V. Fabre, C. Prenat, J. Gingrich et al., Contribution of 5-HT2 Receptor Subtypes to Sleep-Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2A Receptors, Journal of Neuroscience, vol.25, issue.49, pp.11231-11238, 2005.
DOI : 10.1523/JNEUROSCI.1724-05.2005

URL : https://hal.archives-ouvertes.fr/hal-00145492

C. Powell, S. Schoch, L. Monteggia, M. Barrot, M. Matos et al., The Presynaptic Active Zone Protein RIM1?? Is Critical for Normal Learning and Memory, Neuron, vol.42, issue.1, pp.143-153, 2004.
DOI : 10.1016/S0896-6273(04)00146-1

URL : https://hal.archives-ouvertes.fr/hal-00142918

S. Powell, X. Zhou, and M. Geyer, Prepulse inhibition and genetic mouse models of schizophrenia, Behavioural Brain Research, vol.204, issue.2, pp.282-294, 2009.
DOI : 10.1016/j.bbr.2009.04.021

J. Pratt, C. Winchester, N. Dawson, and B. Morris, Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap, Nature Reviews Drug Discovery, vol.172, issue.7, pp.560-579, 2012.
DOI : 10.1038/nrd3649

P. Seeman and S. Kapur, Schizophrenia: More dopamine, more D2 receptors, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.7673-7675, 2000.
DOI : 10.1073/pnas.97.14.7673

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC33999

M. Shahid, G. Walker, S. Zorn, and E. Wong, Asenapine: a novel psychopharmacologic agent with a unique human receptor signature, Journal of Psychopharmacology, vol.3, issue.1, pp.65-73, 2009.
DOI : 10.1177/0269881107082944

E. Simpson, C. Kellendonk, and E. Kandel, A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia, Neuron, vol.65, issue.5, pp.585-596, 2010.
DOI : 10.1016/j.neuron.2010.02.014

H. Takahashi, M. Higuchi, and T. Suhara, The Role of Extrastriatal Dopamine D2 Receptors in Schizophrenia, Biological Psychiatry, vol.59, issue.10, pp.919-928, 2006.
DOI : 10.1016/j.biopsych.2006.01.022

I. Tobler, T. Deboer, and M. Fischer, Sleep and sleep regulation in normal and prion proteindeficient mice, J Neurosci, vol.17, issue.5, pp.1869-1879, 1997.

R. Willi, O. Weinmann, C. Winter, J. Klein, R. Sohr et al., Constitutive Genetic Deletion of the Growth Regulator Nogo-A Induces Schizophrenia-Related Endophenotypes, Journal of Neuroscience, vol.30, issue.2, pp.556-567, 2010.
DOI : 10.1523/JNEUROSCI.4393-09.2010

P. Yadav, A. Abbas, M. Farrell, V. Setola, N. Sciaky et al., The Presynaptic Component of the Serotonergic System is Required for Clozapine's Efficacy, Neuropsychopharmacology, vol.460, issue.3, pp.638-651, 2011.
DOI : 10.1124/jpet.104.080200